Opportunity Information: Apply for PAR 19 300

The National Institute of General Medical Sciences (NIGMS) Bridges to the Doctorate (T32) opportunity (FOA number PAR-19-300) is a discretionary NIH training grant designed to strengthen the pipeline into biomedical Ph.D. programs and, ultimately, the biomedical research workforce. The central aim is to develop a more diverse pool of scientists who earn doctoral degrees and are well prepared to transition into research careers that matter to the nation’s health-related research needs. Rather than funding a single research project, this program supports institutions in building a structured training environment where participants receive coordinated preparation across coursework, lab research, mentoring, and career development.

This FOA specifically supports eligible domestic institutions in developing and implementing training and mentoring approaches that are evidence-based and responsive to how quickly the research enterprise is changing. In practice, that means programs are expected to be intentional and organized: trainees should get strong scientific training, meaningful research experiences, consistent mentorship, and career guidance that helps them move successfully from earlier stages of training into a Ph.D. pathway and onward into the biomedical research workforce. NIGMS signals that strong proposals will blend multiple components (didactic learning, hands-on research, mentoring plans, and career development activities) into one coherent training plan rather than treating these pieces as separate or informal add-ons.

A key compliance point is the clinical trial restriction. Appointed trainees under this FOA are not permitted to lead an independent clinical trial. However, they are allowed to gain clinical trial research experience when the trial is led by a mentor or co-mentor. In other words, the program can expose trainees to clinical research and clinical trial environments as part of their training, but the trainees cannot be the primary leaders responsible for running an independent trial.

Eligibility focuses on U.S.-based institutions. Applicants may include public and state-controlled institutions of higher education, private institutions of higher education, and other eligible domestic organizations as defined in the FOA. The announcement also highlights categories of institutions commonly associated with broadening participation and serving underrepresented communities, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs). At the same time, non-domestic (non-U.S.) entities are not eligible to apply, and non-domestic components of U.S. organizations are also not eligible, reinforcing that the supported training infrastructure must be based in the United States.

From an administrative standpoint, this opportunity is listed under CFDA number 93.859, with the activity category of Health and the funding instrument type of Grant. The agency is the National Institutes of Health (NIH), specifically NIGMS. The record indicates an original closing date of 2021-04-09 and a creation date of 2019-06-19. Details such as the award ceiling and expected number of awards are not provided in the source data excerpt and would need to be confirmed in the full FOA text.

Overall, this Bridges to the Doctorate T32 program is about building institutional training programs that systematically prepare trainees for success in Ph.D. study and biomedical research careers. Competitive applications are likely those that show a clear training structure, strong and well-supervised research experiences, thoughtful mentoring and career development, and a credible plan for helping trainees persist and transition into doctoral programs, all while following NIH rules around clinical trial leadership and domestic eligibility.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "National Institute of General Medical Sciences (NIGMS) Bridges to the Doctorate (T32)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.859.
  • This funding opportunity was created on 2019-06-19.
  • Applicants must submit their applications by 2021-04-09. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Public and State controlled institutions of higher education, Private institutions of higher education, Others.
Apply for PAR 19 300

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs): NIGMS Bridges to the Doctorate (T32) (PAR-19-300)

What is the NIGMS Bridges to the Doctorate (T32) opportunity?

NIGMS Bridges to the Doctorate (T32) (FOA PAR-19-300) is an NIH discretionary institutional training grant that supports institutions in building structured training programs designed to strengthen the pipeline into biomedical Ph.D. programs and, ultimately, the biomedical research workforce.

What is the main goal of this program?

The central aim is to develop a more diverse pool of scientists who earn doctoral degrees and are well prepared to transition into research careers that align with the nation’s health-related research needs.

Does this grant fund a single research project?

No. This is a training grant, not a single-project research award. It supports institutions in creating and running a coordinated training environment that includes scientific preparation, research experiences, mentoring, and career development.

What types of activities are expected to be part of the training program?

The program is expected to integrate multiple components into a coherent training plan. Based on the opportunity description, these components include didactic learning (coursework), hands-on research experiences in labs, organized mentoring, and career development activities that help participants progress into Ph.D. pathways and the biomedical research workforce.

How does NIGMS describe a strong or competitive proposal?

Strong proposals are described as intentional and organized, with coordinated preparation across coursework, lab research, mentoring, and career development. NIGMS signals that these elements should be blended into one structured program rather than treated as separate or informal add-ons.

What does "evidence-based" training and mentoring mean in this context?

The FOA emphasizes that training and mentoring approaches should be evidence-based and responsive to changes in the research enterprise. In practical terms (as described in the provided summary), programs should be deliberately designed and grounded in approaches shown to be effective for trainee development and progression.

Who is eligible to apply for this opportunity?

Eligible applicants are domestic (U.S.-based) institutions and other eligible domestic organizations as defined in the FOA. The categories listed in the provided information include public and state-controlled institutions of higher education and private institutions of higher education, among other eligible domestic entities.

Are non-U.S. (non-domestic) organizations allowed to apply?

No. Non-domestic (non-U.S.) entities are not eligible to apply.

Are non-domestic components of U.S. organizations eligible?

No. Non-domestic components of U.S. organizations are also not eligible, meaning the supported training infrastructure must be based in the United States.

Are minority-serving institutions specifically mentioned?

Yes. The opportunity highlights institution categories commonly associated with broadening participation and serving underrepresented communities, including Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving Institutions, HBCUs, and TCCUs.

What is the role of mentoring in this program?

Mentoring is described as a core part of the structured environment. Trainees are expected to receive consistent mentorship, and mentoring plans should be integrated with research experiences and career guidance to support successful transitions into Ph.D. programs and beyond.

What is the clinical trial restriction for trainees appointed under this FOA?

Appointed trainees are not permitted to lead an independent clinical trial under this FOA.

Can trainees still gain clinical trial experience?

Yes. Trainees may gain clinical trial research experience as part of their training when the clinical trial is led by a mentor or co-mentor. The key distinction is that the trainee cannot be the primary leader responsible for conducting an independent trial.

Which NIH institute and agency are associated with this grant?

The agency is the National Institutes of Health (NIH), and the specific institute named is the National Institute of General Medical Sciences (NIGMS).

What is the funding instrument type and activity category?

The funding instrument type is a Grant, and the activity category is Health.

What CFDA number is associated with this opportunity?

The opportunity is listed under CFDA number 93.859.

What is the FOA number for this Bridges to the Doctorate T32 opportunity?

The FOA number provided is PAR-19-300.

What dates are provided for this opportunity?

The record indicates a creation date of 2019-06-19 and an original closing date of 2021-04-09.

Are the award ceiling and expected number of awards provided?

No. The source data excerpt does not provide an award ceiling or the expected number of awards. Those details would need to be confirmed in the full FOA text.

What is the overall focus of the Bridges to the Doctorate T32 program?

The focus is on building institutional training programs that systematically prepare trainees for success in Ph.D. study and biomedical research careers, with strong training structure, well-supervised research experiences, thoughtful mentoring and career development, and compliance with NIH rules such as the clinical trial leadership restriction and domestic eligibility requirements.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Connecting Kids to Coverage (CKC) HEALTHY KIDS AI/AN

Previous opportunity: Oscillatory Patterns of Gene Expression in Aging and Alzheimers Disease (R01 Clinical Trial Not Allowed)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 19 300

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 19 300) also looked into and applied for these:

Funding Opportunity
Service Centers for Cryoelectron Tomography (U24 - Clinical Trial Not Allowed) Apply for RFA RM 19 009

Funding Number: RFA RM 19 009
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Service Network Hub for Cryoelectron Tomography (U24 - Clinical Trial Not Allowed) Apply for RFA RM 19 010

Funding Number: RFA RM 19 010
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Lipid Signaling in Healthspan and Longevity Regulation (R01 Clinical Trial Not Allowed) Apply for RFA AG 20 039

Funding Number: RFA AG 20 039
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) Apply for PAR 19 302

Funding Number: PAR 19 302
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: NIGMS National and Regional Resources (R24 - Clinical Trial Not Allowed) Apply for PAR 19 301

Funding Number: PAR 19 301
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000
Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional) Apply for RFA AG 20 018

Funding Number: RFA AG 20 018
Agency: National Institutes of Health
Category: Health
Funding Amount: $100,000
Implementation Research on Hypertension Control to Prevent Dementia and Cognitive Decline (R61/R33 Clinical Trial Optional) Apply for RFA AG 20 028

Funding Number: RFA AG 20 028
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R33 Clinical Trial Optional) Apply for PAR 19 304

Funding Number: PAR 19 304
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R21/R33 Clinical Trial Optional) Apply for PAR 19 305

Funding Number: PAR 19 305
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Alzheimers Disease (R01 Clinical Trial Not Allowed) Apply for RFA AG 20 042

Funding Number: RFA AG 20 042
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000
Computational Methods for Integrating Tissue and Single Cell Genomic Data from the Brain (R01 Clinical Trial Not Allowed) Apply for RFA MH 20 300

Funding Number: RFA MH 20 300
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NINDS Child Neurologist Career Development Program (CNCDP) (K12 Clinical Trial Not Allowed) Apply for RFA NS 19 040

Funding Number: RFA NS 19 040
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01 Clinical Trial Not Allowed) Apply for PAR 19 307

Funding Number: PAR 19 307
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Nathan Shock Centers of Excellence in Basic Biology of Aging (P30 Clinical Trial Not Allowed) Apply for RFA AG 20 020

Funding Number: RFA AG 20 020
Agency: National Institutes of Health
Category: Health
Funding Amount: $800,000
Transition to Aging Research for Predoctoral Students (F99/K00) Apply for RFA AG 20 009

Funding Number: RFA AG 20 009
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Nathan Shock Centers Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA AG 20 021

Funding Number: RFA AG 20 021
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
Molecular Mechanisms of Blood-Brain Barrier Function and Dysfunction in Alzheimer's disease and Alzheimer's related dementias (AD/ADRD) (R01 Clinical Trial Not Allowed) Apply for RFA NS 20 004

Funding Number: RFA NS 20 004
Agency: National Institutes of Health
Category: Health
Funding Amount: $499,000
Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional) Apply for PAR 19 312

Funding Number: PAR 19 312
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional) Apply for PAR 19 315

Funding Number: PAR 19 315
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) Apply for RFA RM 19 011

Funding Number: RFA RM 19 011
Agency: National Institutes of Health
Category: Health
Funding Amount: $100,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 19 300", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: